Oncomedicine 2018; 3:74-81. doi:10.7150/oncm.26116

Review

siRNA: A Promising New Tool for Future Breast Cancer Therapy

Amy Huynh1, Chikezie O. Madu2, Yi Lu3✉

1. Department of Biology and Advanced Placement Biology, White Station High School, Memphis, Tennessee 38117. USA. amyhnh@gmail.com
2. Departments of Biology and Advanced Placement Biology, White Station High School, Memphis, Tennessee 38117. USA. maduco@scsk12.org
3. Departments of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA. ylu@uthsc.edu

Abstract

Breast cancer remains a major health concern as it continues to be both the leading cause of cancer-related deaths and most commonly diagnosed form of cancer among women. Recently, RNAi (RNA interference)-based gene therapy has gained attention for its sequence-specific mechanism of gene silencing. RNAi may be induced with the use of short interfering RNAs (siRNAs), which are generated from double-stranded RNA (dsRNA) precursors. Although siRNA has its limitations, siRNA shows enormous potential as a promising tool for the regulation of disease-associated genes, including oncogenes and tumor suppressor genes. In this review, we will discuss the approaches, implications, and challenges of siRNA-mediated RNAi gene therapy regarding various targets of breast cancer.

Keywords: siRNA, Breast Cancer Therapy

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Huynh A, Madu CO, Lu Y. siRNA: A Promising New Tool for Future Breast Cancer Therapy. Oncomedicine 2018; 3:74-81. doi:10.7150/oncm.26116. Available from http://www.oncm.org/v03p0074.htm